In summary, our data suggests that betacellulin plays an important role in the development of increased retinal vascular permeability in diabetes and inhibitors of ADAM-10 or betacellulin signaling might be clinically useful in preventing the development and progression of macular edema in this disease. Here, BTC is linked to macular retinal edema.